469 related articles for article (PubMed ID: 15812624)
41. Effects of levosimendan on acute pulmonary embolism-induced right ventricular failure.
Kerbaul F; Gariboldi V; Giorgi R; Mekkaoui C; Guieu R; Fesler P; Gouin F; Brimioulle S; Collart F
Crit Care Med; 2007 Aug; 35(8):1948-54. PubMed ID: 17568324
[TBL] [Abstract][Full Text] [Related]
42. A comparison of dobutamine and levosimendan on hepatic blood flow in patients with a low cardiac output state after cardiac surgery: a randomised controlled study.
Alvarez J; Baluja A; Selas S; Otero P; Rial M; Veiras S; Caruezo V; Taboada M; Rodriguez I; Castroagudin J; Tome S; Rodriguez A; Rodriguez J
Anaesth Intensive Care; 2013 Nov; 41(6):719-27. PubMed ID: 24180712
[TBL] [Abstract][Full Text] [Related]
43. The calcium sensitizer levosimendan attenuates endotoxin-evoked myocardial dysfunction in isolated guinea pig hearts.
Behrends M; Peters J
Intensive Care Med; 2003 Oct; 29(10):1802-7. PubMed ID: 12879240
[TBL] [Abstract][Full Text] [Related]
44. Hemodynamic effects of levosimendan in patients with low-output heart failure after cardiac surgery.
Labriola C; Siro-Brigiani M; Carrata F; Santangelo E; Amantea B
Int J Clin Pharmacol Ther; 2004 Apr; 42(4):204-11. PubMed ID: 15124978
[TBL] [Abstract][Full Text] [Related]
45. Levosimendan for Hemodynamic Support after Cardiac Surgery.
Landoni G; Lomivorotov VV; Alvaro G; Lobreglio R; Pisano A; Guarracino F; Calabrò MG; Grigoryev EV; Likhvantsev VV; Salgado-Filho MF; Bianchi A; Pasyuga VV; Baiocchi M; Pappalardo F; Monaco F; Boboshko VA; Abubakirov MN; Amantea B; Lembo R; Brazzi L; Verniero L; Bertini P; Scandroglio AM; Bove T; Belletti A; Michienzi MG; Shukevich DL; Zabelina TS; Bellomo R; Zangrillo A;
N Engl J Med; 2017 May; 376(21):2021-2031. PubMed ID: 28320259
[TBL] [Abstract][Full Text] [Related]
46. Comparison between dobutamine and levosimendan for management of postresuscitation myocardial dysfunction.
Huang L; Weil MH; Tang W; Sun S; Wang J
Crit Care Med; 2005 Mar; 33(3):487-91. PubMed ID: 15753736
[TBL] [Abstract][Full Text] [Related]
47. Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression.
Creteur J; Bouckaert Y; Mélot C; Vincent JL
Intensive Care Med; 2006 May; 32(5):790; author reply 791-2. PubMed ID: 16555067
[No Abstract] [Full Text] [Related]
48. Effects of levosimendan versus dobutamine on inflammatory and apoptotic pathways in acutely decompensated chronic heart failure.
Adamopoulos S; Parissis JT; Iliodromitis EK; Paraskevaidis I; Tsiapras D; Farmakis D; Karatzas D; Gheorghiade M; Filippatos GS; Kremastinos DT
Am J Cardiol; 2006 Jul; 98(1):102-6. PubMed ID: 16784930
[TBL] [Abstract][Full Text] [Related]
49. Effects of levosimendan on glomerular filtration rate, renal blood flow, and renal oxygenation after cardiac surgery with cardiopulmonary bypass: a randomized placebo-controlled study.
Bragadottir G; Redfors B; Ricksten SE
Crit Care Med; 2013 Oct; 41(10):2328-35. PubMed ID: 23921271
[TBL] [Abstract][Full Text] [Related]
50. Effects of epinephrine compared with the combination of dobutamine and norepinephrine on gastric perfusion in septic shock.
Seguin P; Bellissant E; Le Tulzo Y; Laviolle B; Lessard Y; Thomas R; Mallédant Y
Clin Pharmacol Ther; 2002 May; 71(5):381-8. PubMed ID: 12011824
[TBL] [Abstract][Full Text] [Related]
51. Levosimendan improves hemodynamics and coronary flow reserve after percutaneous coronary intervention in patients with acute myocardial infarction and left ventricular dysfunction.
De Luca L; Proietti P; Celotto A; Bucciarelli-Ducci C; Benedetti G; Di Roma A; Sardella G; Genuini I; Fedele F
Am Heart J; 2005 Sep; 150(3):563-8. PubMed ID: 16169341
[TBL] [Abstract][Full Text] [Related]
52. Ca2+ sensitizer superior to catecholamine during myocardial stunning?
Meyer K; Klocke RC; Schipke JD; Gams E; Korbmacher B
Eur J Cardiothorac Surg; 2008 Aug; 34(2):326-31. PubMed ID: 18539040
[TBL] [Abstract][Full Text] [Related]
53. Comparison of systemic and regional effects of dobutamine and dopexamine in norepinephrine-treated septic shock.
Levy B; Nace L; Bollaert PE; Dousset B; Mallie JP; Larcan A
Intensive Care Med; 1999 Sep; 25(9):942-8. PubMed ID: 10501749
[TBL] [Abstract][Full Text] [Related]
54. Levosimendan: a retrospective single-center case series.
Berry WT; Hewson RW; Langrish CJ; McKenzie CA; Barrett NA
J Crit Care; 2013 Dec; 28(6):1075-8. PubMed ID: 23998721
[TBL] [Abstract][Full Text] [Related]
55. Levosimendan in Patients with Left Ventricular Dysfunction Undergoing Cardiac Surgery.
Mehta RH; Leimberger JD; van Diepen S; Meza J; Wang A; Jankowich R; Harrison RW; Hay D; Fremes S; Duncan A; Soltesz EG; Luber J; Park S; Argenziano M; Murphy E; Marcel R; Kalavrouziotis D; Nagpal D; Bozinovski J; Toller W; Heringlake M; Goodman SG; Levy JH; Harrington RA; Anstrom KJ; Alexander JH;
N Engl J Med; 2017 May; 376(21):2032-2042. PubMed ID: 28316276
[TBL] [Abstract][Full Text] [Related]
56. [Role of Levosimendan in intensive care treatment of myocardial insufficiency].
Rehberg S; Ertmer C; Van Aken H; Lange M; Bröking K; Morelli A; Westphal M
Anaesthesist; 2007 Jan; 56(1):30-43. PubMed ID: 17131137
[TBL] [Abstract][Full Text] [Related]
57. Myocardial efficiency during levosimendan infusion in congestive heart failure.
Ukkonen H; Saraste M; Akkila J; Knuuti J; Karanko M; Iida H; Lehikoinen P; Någren K; Lehtonen L; Voipio-Pulkki LM
Clin Pharmacol Ther; 2000 Nov; 68(5):522-31. PubMed ID: 11103755
[TBL] [Abstract][Full Text] [Related]
58. The calcium sensitizer levosimendan improves the function of stunned myocardium after percutaneous transluminal coronary angioplasty in acute myocardial ischemia.
Sonntag S; Sundberg S; Lehtonen LA; Kleber FX
J Am Coll Cardiol; 2004 Jun; 43(12):2177-82. PubMed ID: 15193677
[TBL] [Abstract][Full Text] [Related]
59. Cardiovascular effects of levosimendan in the early stages of endotoxemia.
Cunha-Goncalves D; Perez-de-Sa V; Dahm P; Grins E; Thörne J; Blomquist S
Shock; 2007 Jul; 28(1):71-7. PubMed ID: 17510599
[TBL] [Abstract][Full Text] [Related]
60. Intravenous levosimendan treatment is cost-effective compared with dobutamine in severe low-output heart failure: an analysis based on the international LIDO trial.
Cleland JG; Takala A; Apajasalo M; Zethraeus N; Kobelt G
Eur J Heart Fail; 2003 Jan; 5(1):101-8. PubMed ID: 12559222
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
